Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-3.63 Insider Own0.78% Shs Outstand1.10B Perf Week-3.29%
Market Cap11.04B Forward P/E3.75 EPS next Y2.75 Insider Trans-8.18% Shs Float1.09B Perf Month-9.26%
Income-3982.00M PEG- EPS next Q0.59 Inst Own52.60% Short Float2.74% Perf Quarter-16.55%
Sales16.28B P/S0.68 EPS this Y-297.90% Inst Trans0.44% Short Ratio3.11 Perf Half Y15.88%
Book/sh9.10 P/B1.13 EPS next Y5.09% ROA-7.80% Target Price12.20 Perf Year-1.81%
Cash/sh1.62 P/C6.34 EPS next 5Y5.77% ROE-36.60% 52W Range8.44 - 13.30 Perf YTD6.63%
Dividend- P/FCF- EPS past 5Y-32.00% ROI-9.50% 52W High-22.63% Beta1.45
Dividend %- Quick Ratio0.70 Sales past 5Y-3.30% Gross Margin46.90% 52W Low21.92% ATR0.33
Employees39717 Current Ratio1.00 Sales Q/Q-8.60% Oper. Margin-20.50% RSI (14)43.80 Volatility3.17% 2.98%
OptionableYes Debt/Eq2.50 EPS Q/Q10.50% Profit Margin-24.50% Rel Volume0.65 Prev Close10.36
ShortableYes LT Debt/Eq2.23 EarningsApr 28 BMO Payout- Avg Volume9.58M Price10.29
Recom2.80 SMA20-2.45% SMA50-5.87% SMA200-1.66% Volume6,237,482 Change-0.68%
May-04-21Downgrade UBS Buy → Neutral $15 → $11
Apr-07-21Resumed RBC Capital Mkts Sector Perform $11
Nov-25-20Initiated Oppenheimer Perform
Aug-06-20Upgrade Barclays Underweight → Equal Weight $10 → $13
Jul-27-20Resumed Goldman Neutral $12
Jun-01-20Upgrade SunTrust Hold → Buy
Apr-24-20Resumed Citigroup Neutral $10
Apr-06-20Upgrade UBS Neutral → Buy $14 → $12
Feb-24-20Downgrade Edward Jones Hold → Sell
Nov-12-19Upgrade JP Morgan Underweight → Neutral $8
Oct-17-19Upgrade Gabelli & Co Hold → Buy
Aug-07-19Downgrade Evercore ISI Outperform → In-line
Jul-19-19Initiated Wolfe Research Peer Perform
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19Resumed Credit Suisse Neutral
Jul-05-19Upgrade Argus Hold → Buy
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
May-05-21 08:00AM  
May-04-21 11:14AM  
May-03-21 08:00AM  
Apr-29-21 04:18PM  
07:05AM  
Apr-28-21 04:26PM  
02:30PM  
02:29PM  
12:11PM  
10:55AM  
10:47AM  
10:10AM  
08:07AM  
07:40AM  
07:29AM  
07:00AM  
06:15AM  
Apr-27-21 08:00PM  
08:00AM  
Apr-23-21 11:09AM  
Apr-20-21 10:13AM  
Apr-19-21 08:00AM  
Apr-16-21 12:58PM  
Apr-15-21 08:00AM  
Apr-13-21 06:09AM  
Apr-08-21 07:54AM  
07:30AM  
03:00AM  
Apr-06-21 09:42AM  
09:28AM  
07:30AM  
Mar-26-21 05:51AM  
Mar-21-21 05:51AM  
Mar-08-21 02:46PM  
Mar-06-21 04:06PM  
Mar-03-21 05:51AM  
Mar-01-21 04:00PM  
Feb-28-21 07:00AM  
Feb-26-21 08:00AM  
Feb-21-21 06:20AM  
Feb-20-21 06:30AM  
Feb-18-21 11:08AM  
07:15AM  
Feb-12-21 12:40AM  
Feb-11-21 10:25AM  
09:14AM  
Feb-10-21 06:00PM  
01:50PM  
10:19AM  
09:31AM  
09:26AM  
07:52AM  
07:48AM  
07:16AM  
07:00AM  
06:15AM  
03:41AM  
Feb-09-21 11:50AM  
Feb-08-21 11:00PM  
10:33AM  
Feb-07-21 06:36AM  
Jan-31-21 05:51AM  
Jan-26-21 05:48AM  
Jan-14-21 05:17PM  
Jan-09-21 05:51AM  
Jan-08-21 03:01PM  
Jan-07-21 04:00PM  
08:00AM  
Jan-06-21 06:06AM  
Jan-04-21 05:51AM  
Jan-02-21 05:45PM  
Dec-29-20 06:06AM  
Dec-21-20 05:27PM  
Dec-18-20 10:25AM  
Dec-17-20 06:06AM  
Dec-16-20 01:57PM  
Dec-15-20 10:55AM  
Nov-27-20 09:40AM  
02:22AM  
Nov-26-20 06:43AM  
Nov-23-20 08:52AM  
Nov-20-20 03:00PM  
11:17AM  
Nov-19-20 09:41PM  
09:52AM  
Nov-18-20 09:40PM  
09:44AM  
Nov-17-20 08:48PM  
Nov-15-20 10:55AM  
Nov-14-20 03:20PM  
10:51AM  
Nov-13-20 01:25PM  
10:29AM  
Nov-12-20 09:01PM  
07:21AM  
Nov-11-20 08:55PM  
03:55PM  
Nov-10-20 08:54PM  
03:10PM  
09:16AM  
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sabag MarkSee "Remarks" belowMar 16Sale11.22127,2441,427,61420,598Mar 17 04:03 PM
O'Grady Brendan P.EVP, North America CommercialMar 05Sale10.5411,436120,58014,868Mar 08 04:09 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 04Sale10.5713,930147,1862,974Mar 08 04:12 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 04Sale10.576,01263,52377,976Mar 08 04:03 PM
O'Grady Brendan P.EVP, North America CommercialMar 04Sale10.598,17286,51114,868Mar 08 04:09 PM
Nazzi GianfrancoEVP, International MarketsMar 04Sale10.5812,935136,9090Mar 08 04:08 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 04Sale10.579,515100,53673,454Mar 08 04:07 PM
Drape EricExecutive VP Global OperationsMar 04Sale10.586,18365,44355,048Mar 08 04:04 PM
Daniell RichardExec. VP, European CommercialMar 04Sale10.587,51379,52120,280Mar 08 04:02 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 03Sale10.866066,58370,058Mar 04 04:02 PM
Daniell RichardExec. VP, European CommercialMar 03Sale10.8899310,80311,873Mar 04 04:01 PM
Nazzi GianfrancoEVP, International MarketsMar 03Sale10.881,40015,2310Mar 04 04:04 PM
O'Grady Brendan P.EVP, North America CommercialMar 03Sale10.864635,02915,571Mar 04 04:05 PM
O'Grady Brendan P.EVP, North America CommercialMar 02Sale10.8515,085163,60114,868Mar 04 04:05 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 02Sale10.8250,000540,89064,064Mar 04 04:03 PM
Stark David MatthewExec. VP Chief Legal OfficerMar 01Sale10.8318,430199,6122,974Mar 02 04:10 PM
Nazzi GianfrancoEVP, International MarketsMar 01Sale10.8775,587821,9250Mar 02 04:07 PM
O'Grady Brendan P.EVP, North America CommercialMar 01Sale10.9173,127798,02329,953Mar 02 04:07 PM
Fridriksdottir HafrunExecutive VP, Global R&DMar 01Sale10.8310,912118,186114,064Mar 02 04:05 PM
Drape EricExecutive VP Global OperationsMar 01Sale10.859,795106,28549,291Mar 02 04:04 PM
Dethlefs SvenEVP Global Marketing&PortfolioMar 01Sale10.837,48681,07969,264Mar 02 04:03 PM
Daniell RichardExec. VP, European CommercialMar 01Sale10.8520,598223,50710,765Mar 02 04:02 PM
Stark David MatthewExec. VP Chief Legal OfficerFeb 16Sale11.123,92643,6692,974Feb 17 04:09 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 16Sale11.122,09823,336103,294Feb 17 04:07 PM
Drape EricExecutive VP Global OperationsFeb 16Sale11.132,07923,13539,572Feb 17 04:06 PM
Stark David MatthewExec. VP Chief Legal OfficerFeb 09Sale12.6965,312829,1032,974Feb 11 04:12 PM
O'Grady Brendan P.EVP, North America CommercialFeb 09Sale12.6920,694262,70078,146Feb 11 04:08 PM
Nazzi GianfrancoEVP, International MarketsFeb 09Sale12.7221,635275,21760,410Feb 11 04:07 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 09Sale12.6929,496374,437100,037Feb 11 04:05 PM
Drape EricExecutive VP Global OperationsFeb 09Sale12.7217,979228,70937,725Feb 11 04:04 PM
Dethlefs SvenEVP Global Marketing&PortfolioFeb 09Sale12.6929,657376,48159,404Feb 11 04:03 PM
Daniell RichardExec. VP, European CommercialFeb 09Sale12.7268,422870,38910,765Feb 11 04:02 PM
Daniell RichardExec. VP, European CommercialSep 09Sale8.983332,99210,765Sep 10 09:04 AM
Crane Rosemary ADirectorAug 11Sale11.902,86034,03833,509Aug 13 04:07 PM